Belite Bio completes its phase 3 trial for tinlarebant, a potential first treatment for Stargardt disease, with results ...

We ask leading experts in the field what eye disease they would cure and why. In celebration of Ophthalmology Times' 50th ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

A panelist discusses how a 50-year-old male patient with stabilized keratoconus achieved excellent visual outcomes with an IC-8 small aperture IOL by targeting slight myopia to optimize the defocus ...

A panelist discusses how a 40-year-old female patient seeking freedom from glasses experienced a complicated course with a light adjustable lens that resulted in poor visual quality and 22 clinic ...

A panelist discusses how the IC-8 Apthera small aperture IOL functions as a pinhole-based optical system that blocks distorted peripheral light while allowing focused light from both distance and near ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Kwangdong, a top 5 pharmaceutical and healthcare company in Korea, is actively involved in research and development ...

Optain Health secures $26 million in Series A funding to enhance AI-driven retinal disease detection and expand its ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...